Scientific & Clinical Advisory Board
Prosensa has established a scientific advisory board with renowned scientific experts with a broad and diversified background. We are proud to closely interact with these experts and to be able to access their expertise and network.
The Prosensa Scientific & Clinical advisory board:
-
Gert-Jan B. van Ommen, Ph.D - Chairman
Gert-Jan B. van Ommen, is head of Department of Human Genetics of Leiden University Medical Center (LUMC), and founder of the Leiden Genome Technology Center.
-
Kay Davies, Ph.D
Kay Davies, is Professor of Anatomy at the University of Oxford, honorary Director of the MRC Functional Genomics Unit and Head of the Department of Physiology, Anatomy and Genetics.
-
Kenneth H. Fischbeck, Ph.D
Kenneth H. Fischbeck is chief of the Neurogenetics Branch, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health, USA.
-
Peter Goodfellow, Ph.D, D.Phil
Peter Goodfellow, D.Phil. is a Science Advisor to Abingworth Life Sciences and is a Board Member of Prosensa Therapeutics BV.
-
Herbert L. Heyneker, Ph.D
Herbert L. Heyneker is a Director at ProFibrix, BV and was untill recently SVP R&D at Crucell. Prior to that he was Chief Technical Officer & cofounder of Eos Biotechnology.
-
Christopher E. Pearson, Ph.D
Christopher E. Pearson is Senior Scientist at 'The Hospital for Sick Children', Genetics & Genome Biology; and Associate Professor at the University of Toronto, Molecular Genetics, Canada.
-
Gerard Platenburg
Gerard Platenburg is currently CEO of ISA Pharmaceuticals B.V., a clinical stage company in the field of therapeutic vaccines. Gerard is one of Prosensa's founders & CEO till end 2008.